Drug intelligence / Profile preview

DJ-1 siRNA

Development stage
Preclinical
Lead developer
Oregon State University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

DJ-1 siRNA is a small interfering RNA specifically designed to silence expression of the DJ-1 gene (also known as PARK7), a multifunctional protein implicated in cancer cell survival, resistance to chemotherapy, oxidative stress defense, and suppression of apoptosis. By targeting DJ-1 mRNA, DJ-1 siRNA downregulates DJ-1 protein expression, impairing cancer cell proliferation, migration, and survival. Mechanistically, DJ-1 siRNA exerts anti-cancer effects through inhibition of the Akt signaling pathway, restoration of p53-mediated apoptosis and cell cycle arrest, reduction of Nrf2-mediated antioxidant response, and increased sensitivity to chemotherapeutic agents such as cisplatin or adriamycin. These properties have been evaluated in preclinical cancer models, particularly for platinum-resistant ovarian cancer and multidrug-resistant breast cancer, using various targeted or nanoparticle-based delivery systems[1][2][3].

Other names
DJ-1 small interfering RNADJ1 small interfering RNADJ 1 small interfering RNAPARK7 siRNAPARK-7 siRNAPARK 7 siRNA
02

Targets

PARK7 (Protein deglycase DJ-1)

Beyond the preview

Go deeper on DJ-1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DJ-1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call